Showing 971-980 of 1690 results for "".
Dementia Insights: Cognitive Consequences of Perimenopause
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-cognitive-consequences-ofperimenopause/31525/A possible contribution of perimenopause should be considered when evaluating women with cognitive complaints.Medical Marijuana and Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-parkinsons-disease/30245/Given limited treatments available, investigating potential benefits of cannabinoids can offer cautious optimism over controversy.Can the Private Practice Survive in the Age of Consolidation?
https://practicalneurology.com/columns/practice-management/can-the-private-practice-survive-in-the-age-of-consolidation/30326/In the rapidly changing health care economy, increasing regulation and the expanding influence of third-party payers are diminishing the physician's role.Stroke Busters: Mobile Stroke Units Offer a New Approach to Care
https://practicalneurology.com/diseases-diagnoses/imaging-testing/stroke-busters-mobile-stroke-units-offer-a-new-approach-to-care/30593/Calling 911 in Cleveland might deliver a highly specialized vehicle to suspected stroke patients. What's behind the new intervention?Single Isolated Concussion Part I: Definitions, Classification, and Prognosis
https://practicalneurology.com/diseases-diagnoses/tbi/single-isolated-concussion-part-i-definitions-classification-and-prognosis/30268/Providing sound advice after a single isolated concussion.Sleep & Neurodevelopment
https://practicalneurology.com/diseases-diagnoses/sleep/sleep--neurodevelopment/30107/Sleep characterization in children may have a role in evaluation for risk of impaired development, behavior, mood, and self-regulation.Seeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin TherapeuticsEmerging Therapies for Progressive Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/emerging-therapies-for-progressive-multiple-sclerosis/30125/A number of agents with putative neuroprotective effects have shown promise in recent clinical trials.Migraine and the Presidency: Clinical Lessons from History?
https://practicalneurology.com/columns/practice-management/migraine-and-the-presidency-clinical-lessons-from-history/30790/History reveals some interesting facts about migraine, perceptions of chronic headaches, and the impact of migraine on the power to leadIncorporating Cultural Considerations Into Neuropalliative Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/incorporating-cultural-considerations-into-neuropalliative-care/35443/Neuropalliative teams can meet the cultural needs of individuals and families through transdisciplinary collaboration.